About us

X

Moshe has more than 20 years of experience in the medical device industry, having taken leadership roles within start-up companies and global corporates. Before joining AccuLine, Moshe served as CEO of Intratech Medical, where he continues to serve as an Executive Chairman today. Prior to that, Moshe served as  CEO at Sanolla, VP of Strategy at NovaSight, and business unit director at Lumenis and Johnson & Johnson.

Moshe holds a BA in Economics and Business Administration and an MSc in Business Administration – both from Tel-Aviv university. LinkedIn

X

With over 25 years of experience in medical devices and technology, specializing in leading multidisciplinary teams and driving innovation, Amit brings invaluable expertise to our mission of advancing non-invasive cardiovascular diagnostics. Prior to joining AccuLine, Amit held the position of CTO at Nuvo, a medical device company pioneering remote pregnancy monitoring. There, he led all technological activities, including hardware, software, algorithm development, data science, and clinical affairs. Before Nuvo, Amit was the VP of R&D at Firefly Neuroscience, where he transformed a founding team into a mature, high-performing group of neuroscientists, engineers, and data scientists. Earlier in his career, Amit held several leadership roles in the IT industry, specializing mainly in the field of natural language processing. Amit holds a B.S. in Computer Science (cum laude) from Tel Aviv University and a Ph.D. in Neuroscience from the Technion – Israel Institute of Technology. He has authored over 40 publications spanning engineering, life sciences, and clinical research and holds 10 patents.

X

Don is a seasoned medical device executive with over 40 years of experience in cardiovascular diagnostics. Prior to joining AccuLine, Don served as the President & CEO of CorVista Health for nine years, where he successfully raised over $115 million and secured FDA approval for its AI-powered cardiac diagnostic platform. Before CorVista, Don was the founder and CEO of Sapheon, a pioneering venous disease treatment company, which was acquired by Covidien for $238 million. Don has also held senior leadership roles at Medtronic, Guidant, Ventritex, and Intermedics, managing international sales and marketing. His extensive expertise in fundraising, market expansion, and regulatory strategy has positioned him as a key leader in the MedTech industry. With a strong track record of guiding medical device companies through development, approval, and commercialization, Don brings invaluable experience to AccuLine’s mission to revolutionize cardiovascular diagnostics. Don holds a B.Ch.E. in Chemical Engineering from Georgia Tech and an M.B.A. from Emory University. He also has dozens of patents to his name.

X

Shai Revzen is an Associate Professor in the departments of Electrical Engineering and Computer Science at the University of Michigan, Ann Arbor, and a founding member of the Michigan Robotics Institute.  Prof. Revzen holds a PhD in biomechanics from the University of California, Berkeley, an MSc in computer science from the Hebrew University in Jerusalem and did his post-doctoral in University of Pennsylvania. He heads the BIRDS Lab, which focuses on the crucial role of mechanics in robot motion. Prof. Revzen has more than 100 scientific publications in top engineering, biology and applied mathematics journals, and several registered patents. LinkedIn

X

Aharon Frimerman, M.D, is a cardiologist and head of the catheterization laboratory unit at Hillel-Yaffe Medical Center, Israel, as well as a Professor of Cardiology at the faculty of medicine of the Technion, the Israeli Institute of Technology. Prof.  Frimerman serves as a member of the editorial board at the journal of the Israel Heart Society, reviewer at the Journal of Interventional Cardiology and member of the interventional cardiology devices committee for the Israeli ministry of health. He has won several awards from the Israeli Heart Society, the Israeli ministry of health, Technion’s faculty of medicine, and Hillel-Yaffe medical center for excellence in research and in teaching. Prof. Frimerman has published dozens of scientific papers and has 9 patents under his name. Prof. Frimerman also served as an advisor to Boston Scientific, Siemens, RDC Medical, Angioslide, Sync-Rx, Elcam Medical, and Naiot Technological Center.

X

Joe is one of the most connected and trusted leaders in global MedTech. As founder, chairman, and CEO of The Mullings Group (TMG) Companies, including TMG Search and Dragonfly, he has spent 30+ years shaping the industry, leading more than 9,000 successful executive searches for over 900 healthcare companies worldwide, from multi-billion-dollar strategics to breakout startups. Joe also founded TMGPulse, hosts the award-winning TrueFuture docuseries, and has built a powerful media platform that helps technologies earn attention, adoption, and market pull. His voice and work have been featured across Forbes, CNBC, Business Insider, Yahoo Finance, NY Post, and Monster. Joe’s involvement across the ecosystem runs deep, from the CRF-TCT planning committee to leadership roles at Mayo Clinic, along with long-standing partnerships with LSI, DeviceTalks Boston, AdvaMed, MedTech Conference, and MedTech Color.

X

Timothy D. Henry, MD, MSCAI is the Medical Director of The Carl and Edyth Lindner Center for Research and Education at The Christ Hospital in Cincinnati, Ohio and former President of SCAI – The Society for Cardiovascular Angiography and Interventions. Prior to The Lindner Research Center, Dr. Henry served as the Chief of Cardiology at the Smidt Heart Institute at Cedars-Sinai Medical Center and as a Professor of Medicine at both Cedars-Sinai and UCLA. He was the Director of Research at the Minneapolis Heart Institute Foundation at Abbott Northwestern Hospital in Minneapolis and a Professor of Medicine at the University of Minnesota from 2001 to 2013. He has published over 750 manuscripts and book chapters and has served as principal investigator and steering committee member of multiple large, multicenter research trials in acute myocardial infarction, refractory angina, and regenerative medicine with gene and stem cell therapy. Dr. Henry has been named to the Best Doctors in America list each year for the last 15 years, became a Master Fellow of SCAI in 2015, received the American Heart Association’s Heart and Stroke Hero Award in Research in 2013, the LUMEN Global Lifetime Achievement Award in MI in 2012, and most recently was awarded the Cincinnati 2021 Health Care Heroes Award, Innovator.

X

Prof. Gad Keren, M.D., is a world-renowned cardiologist with a remarkable legacy as Professor Emeritus of Cardiology at the Sackler School of Medicine, Tel Aviv University, Director of Cardiology at Assuta Medical Centers, and former Chair of Cardiology at Tel Aviv Sourasky Medical Center, where he mentored a generation of leading cardiologists.

His international training includes fellowships at the Albert Einstein College of Medicine, the National Institutes of Health, and the Washington Hospital Center. He has held senior academic roles, among them the Chaim Sheba Chair of Cardiology and Vice Dean for Medical Education at Tel Aviv University.

Prof. Keren’s expertise spans hemodynamics, heart failure, cardiac imaging, and translational cardiovascular innovation. His pioneering research has resulted in more than 400 peer-reviewed publications and multiple patents, and he has played a central role in founding several medtech companies – including V-Wave, acquired by Johnson & Johnson in 2024.

X

Tom D. Thacher, MD, is the Parker D. Sanders and Isabella G. Sanders Professor of Family Medicine at the Mayo Clinic in Rochester, Minnesota. He provides both outpatient and inpatient care in his active practice, and he trains Family Medicine residents and medical students. He is engaged in research related to implementation of AI innovations in primary care and has over 130 medical journal publications. At Mayo Clinic, he is the Vice-Chair of Research in Family Medicine, working to build research capacity in the department. He has served as the Chair of the Mayo Clinic Quality Review Board and is on the Editorial Board of the Mayo Clinic Proceedings journal.

X

Dr. Olshansky is a distinguished figure in cardiology, with a career spanning decades of clinical practice, academic leadership, and groundbreaking research. He serves as a Professor Emeritus of Medicine at the University of Iowa and holds multiple active roles in clinical cardiology across Iowa and Illinois. Renowned for his expertise in cardiac electrophysiology, Dr. Olshansky has been a mentor to countless fellows and residents, guiding the next generation of cardiologists. Dr. Olshansky has authored over 400 peer-reviewed publications, led more than 50 clinical studies as Principal Investigator, contributed to 59 book chapters and written 4 books. He is an editor of the ESC Textbook on Cardiovascular Medicine and, for 30 years, an editor and contributor to UpToDate. His numerous honors include the several Elite Reviewer Awards from JACC and the Lewis E. January Clinical Teacher of the Year Award. His global contributions as a visiting professor, invited speaker at international conferences, and co-author of pivotal research publications have shaped modern approaches to arrhythmia management, mechanistic understanding of arrhythmias, syncope evaluation, autonomic disorders, heart failure care and cardiovascular risk prediction.